# Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer

> **NCT01322152** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 52 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** irinotecan, capecitabine

## Key facts

- **NCT ID:** NCT01322152
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2013-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322152, "Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01322152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*